The present invention is directed to fibrate compositions having improved pharmacokinetic profiles and reduced fed/fasted variability. The fibrate particles of the composition have an effective average particle size of less than about 2000 nm....http://www.google.fr/patents/US7931917?utm_source=gb-gplus-shareBrevet US7931917 - Nanoparticulate fibrate formulations
